Advantages
Clinically proven to inform the selection of safe and efficacious treatments.
Includes assessment of all molecular biomarkers indicated in the National Comprehensive Cancer Network (NCCN) guidelines.
Evaluates additional clinically relevant biomarkers.
Chemo-response profiling of live tumor / tumor associated cells aids the accurate selection of chemotherapy drugs.
Guides treatment selection in label compliant as well as off-label settings.